Kymera Therapeutics KYMR announced that it has begun dosing patients in the phase IIb BREADTH study of KT-621 for moderate-to ...

A destructive plant pathogen has long puzzled scientists with its ability to move swiftly through crops and cause sudden, ...

Menopause can accelerate age-related weight gain, increasing a woman’s odds of becoming overweight or obese, researchers said ...

Former Kerala High Court judge Justice C Siri Jagan, known for his suo motu interventions in public interest matters and his ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial results for the fourth quarter and full year 2025 and provided a business update.

A busy week of quarterly results delivered regulatory milestones, broker upgrades and mixed share-price moves across ASX healthcare. ... Read More The post Scott Power: Quarterly results build ...

Teva delivers 3 consecutive years of growth - 2025 revenues of $17.3 billion, an increase of 4% year-over-year (YoY) in U.S.

National HealthCare is delivering robust earnings growth, with EBITDA projected to grow 46.1%. Read why I reiterate my buy ...

Willdan's architect-to-builder model secures recurring, high-margin revenue, with organic net revenue growth at 20% Y/Y. See ...

With Category I CPT reimbursement now available for AI-enabled coronary plaque analysis, Circle’s FDA-cleared AI technology and flexible Elevate pricing model make it easier for healthcare ...

One Platform for Every Advanced Cardiac Imaging Need.The new cvi42 v6.4 release expands Circle CVI's all-in-one solution, delivering advanced MR automation, comprehensive ...

Electrophysiology has emerged as a central pillar in the intersection of neuroscience and the treatment of neuropsychiatric ...